Suppression of heat- and polyglutamine-induced cytotoxicity by nonsteroidal anti-inflammatory drugs

被引:17
|
作者
Ishihara, K [1 ]
Yamagishi, N [1 ]
Hatayama, T [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Biochem, Yamashima Ku, Kyoto 6078414, Japan
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 22期
关键词
heat shock proteins; indomethacin; nonsteroidal anti-inflammatory drugs; nordihydroguaiaretic acid; polyglutamine disease;
D O I
10.1111/j.1432-1033.2004.04419.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have shown that sodium salicylate activates the heat shock promoter and induces the expression of heat shock proteins (hsps), with a concomitant increase in the thermotolerance of cells. To determine whether these effects are generally displayed by nonsteroidal anti-inflammatory drugs (NSAIDs), we examined the effects of a cyclooxygenase inhibitor, indomethacin, and a lipoxygenase inhibitor, nordihydroguaiaretic acid. Both inhibitors up-regulated the hsp promoter at 37degreesC through the activation of heat shock factors, and increased cellular levels of hsps in mammalian cells, although the degree of the expression of hsps and thermotolerance of cells differed depending on the drugs. Furthermore, NSAIDs such as sodium salicylate and indomethacin suppressed the protein aggregation and apoptosis caused by an expanded polyglutamine tract in a cellular model of polyglutamine disease. These findings suggest that NSAIDs generally induce the expression of hsps in mammalian cells and may be used for the protection of cells against deleterious stressors and neurodegenerative diseases.
引用
收藏
页码:4552 / 4558
页数:7
相关论文
共 50 条
  • [21] Nonsteroidal anti-inflammatory drugs and pharyngitis
    Mazzone, Stuart B.
    Kulasekaran, Anuradha
    Shea, Tim
    Adegoke, Oluwajoba
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (12)
  • [22] The nonsteroidal anti-inflammatory drugs controversy
    Yeomans, ND
    Garas, G
    Hawkey, CJ
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2000, 29 (04) : 791 - +
  • [23] PHOTOSENSITIVITY TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    FIGUEINEDO, A
    TEIXEIRA, E
    POIARESBAPTISTA, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1989, 28 (02) : 139 - 140
  • [24] Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
    Kim, Stephen J.
    Flach, Allan J.
    Jampol, Lee M.
    SURVEY OF OPHTHALMOLOGY, 2010, 55 (02) : 108 - 133
  • [25] A review of nonsteroidal anti-inflammatory drugs
    Schellack, Natalie
    Schellack, Gustav
    Fourie, Johani
    SA PHARMACEUTICAL JOURNAL, 2015, 82 (03) : 8 - 18
  • [26] Topical nonsteroidal anti-inflammatory drugs
    Bhat, Chirag
    Rosenberg, Hans
    James, Daniel
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (36) : E1231 - E1231
  • [28] Novel nonsteroidal anti-inflammatory drugs
    Boutsen, Y
    Esselinckx, W
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1999, 62 (04): : 421 - 424
  • [29] Therapy with nonsteroidal, anti-inflammatory drugs
    Bauer, H
    Märker-Hermann, E
    ORTHOPADE, 2003, 32 (12): : 1088 - 1094
  • [30] Nonsteroidal anti-inflammatory drugs and the kidney
    Stürmer, T
    Elseviers, MM
    De Broe, ME
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 161 - 163